Business Context and Reporting Period
Company: Bone Biologics Corp (BBLG)
Filing Type: Form 8-K (Current Report)
Date of Report: January 9, 2024 (Event Date: January 10, 2024)
Reporting Period: Specific event notification regarding listing status.
Key Financial Metrics
This filing is a current report regarding corporate governance and listing status. It does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing text does not provide a clear value for any financial metric.
Material Changes
Listing Status: The company announced on January 10, 2024, that it has regained compliance with the Nasdaq Capital Market listing standards. This resolves a prior deficiency regarding listing requirements.
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release (Exhibit 99.1) confirming the restoration of compliance. No forward-looking guidance, financial outlook, or specific risk factors are detailed within the text of this 8-K.
Investor Verification Checklist
- Verify the specific Nasdaq listing standard that was previously non-compliant and the actions taken to resolve it.
- Review the attached press release (Exhibit 99.1) for additional context on the compliance timeline.
- Confirm the current trading status of Common Stock (BBLG) and Warrants (BBLGW) on the Nasdaq Capital Market.
- Check subsequent filings for any financial updates or operational changes related to the compliance restoration.